Article
Low frequency of CHEK2 mutations in familial pancreatic cancer.
Familial cancer - 1 Jan 2006
Bartsch Detlef K, Krysewski Kristina, Sina-Frey Mercedes, Fendrich Volker, Rieder Harald, Langer Peter, Kress Ralf, Schneider Margarete, Hahn Stephan A, Slater Emily P
Abstract excerpt
Familial pancreatic cancer (FPC) is a rare tumour syndrome and its underlying major gene defect is still unknown. Recently, CHEK2 has been identified as multi-organ cancer susceptibility gene associated with a predisposition to breast, prostate and colon cancer. Since these cancers also are associated with some FPC families, we have analysed 35 index patients of German FPC families for CHEK2 mutations. The CHEK2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
